Advanced research on risk factors of type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue SUPPL.2, 2012, Pages 32-39

  Bi, Yufang ^a,b   Wang, Tiange ^a,b   Xu, Min ^a,b   Xu, Yu ^a,b   Li, Mian ^a,b   Lu, Jieli ^a,b   Zhu, Xiaolin ^a,b   Ning, Guang ^a,b  

^a BEIJING HOSPITAL   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Prevalence; Risk factors; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT FACTOR D; FETUIN A; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; ALLELE; DIET; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INFLAMMATION; LEUKOCYTE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING;

ALCOHOL DRINKING; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; PREVALENCE; RISK FACTORS; SEDENTARY LIFESTYLE; SMOKING;

EID: 84871836014     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2352     Document Type: Review

References (99)

1. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011; 34(6): 1249-57.
2. International Diabetes Federation. IDF Diabetes Atlas. Epidemiology and morbidity. In: International Diabetes Federation. Available at http://www.idf.org Accessed on 1 July 2011.
3. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12): 1090-101.
4. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445(7130): 881-5.
5. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglycerides levels. Science 2007; 316(5829): 1331-6.
6. Kong A, Steinthorsdottir V, Masson G, et al. Parental origin of sequence variants associated with complex diseases. Nature 2009; 462(7275): 868-74.
7. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42(2): 105-16.
8. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301(20): 2129-40.
9. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345(11): 790-7.
10. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325(3): 147-52.
11. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298(22): 2654-64.
12. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005; 28(3): 719-25.
13. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27(3): 813-23.
14. Stefan N, Fritsche A, Weikert C, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008; 57(10): 2762-7.
15. Ix JH, Wassel CL, Kanaya AM, et al. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008; 300(2): 182-8.
16. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006; 114(1): 106-12.
17. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 2008; 31(2): 194-200.
18. Popkin BM, Horton S, Kim S, Mahal A, Shuigao J. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev 2001; 59(12): 379-90.
19. Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46(9): 1190-8.
20. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008; 31(5): 893-8.
21. Huang Y, Chen Y, Xu M, et al. Low-grade albuminuria is associated with carotid intima-media thickness in chinese type 2 diabetic patients. J Clin Endocrinol Metab 2010; 95(11): 5122-8.
22. Tan JR, Chen YH, Bi YF, et al. Prehypertension is associated with atherosclerosis in type 2 diabetes. J Diabetes 2010; 2(1): 56-63.
23. Bloomgarden Z, Guang N. Hypertension in patients with diabetes: questions. J Diabetes 2010; 2(3): 128-9.
24. Liu YP, Zhan WW, Zhang YF, et al. Carotid intima-media thickness and stiffness in relation to type 2 diabetes in Chinese. Endocrine 2007; 31(3): 289-93.
25. Chen Y, Huang Y, Li X, et al. Association of arterial stiffness with HbA1c in 1000 type 2 diabetic patients with or without hypertension. Endocrine 2009; 36(2): 262-7.
26. Gui MH, Qin GY, Ning G, et al. The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population. Diabetes Res Clin Pract 2009; 85(2): 213-9.
27. International Diabetes Federation. The economic impacts of diabetes. Available at http://www.idf.org/book/export/html/23140 Accessed on 20 July 2011.
28. World Health Organization. Chronic Diseases a vital investment. Available at http://www.who.int/chp/chronic_disease_report/full_report.pdf Accessed on 1 July 2011.
29. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 2002; 288(20): 2554-60.
30. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33(11): 2477-83.
31. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292(8): 927-34.
32. Halton TL, Willett WC, Liu S, et al. Potato and French fry consumption and risk fo type 2 diabetes in women. Am J Clin Nutr 2006; 83(2): 284-90.
33. Tucker LA, Friedman GM. Television viewing and obesity in adult males. Am J Public Health 1989; 79(4): 516-8.
34. Tucker LA, Bagwell M. Television viewing and obesity in adult females. Am J Public Health 1991; 81(7): 908-11.
35. Coakley EH, Rimm EB, Colditz G, Kawachi I, Willett W. Predictors of weight change in men. Int J Obes Relat Metab Disord 1998; 22(2): 89-96.
36. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003; 289(14): 1785-91.
37. Ching PLYH, Willett WC, Rimm EB, Colditz GA, Gortmaker SL, Stampfer MJ. Activity level and risk of overweight in male health professionals. Am J Public Health 1996; 86(1): 25-30.
38. Lank NH, Vickery CE, Cotugna N, Shade DD. Food commercials during television soap operas. J Community Health 1992; 17(6): 377-84.
39. Dietz WH Jr, Gortmaker SL. Do we fatten our children at the television set? Pediatrics 1985; 75(5): 807-12.
40. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001; 161(12): 1542-8.
41. Ainsworth BE, Haksell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25(1): 71-80.
42. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298(222): 2654-64.
43. Barrett-Connor E, Khaw KT. Cigarette smoking and increased central adiposity. Ann Intern Med 1989; 111(10): 783-7.
44. Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 1989; 261(8): 1169-73.
45. Meikle AW, Liu XH, Taylor GN, Stringham JD. Nicotine and cotinine effects on 3 alpha hydroxysteroid dehydrogenase in canine prostate. Life Sci 1988; 43(23): 1845-50.
46. Bruin JE, Petre MA, Raha S, Morrison KM, Gerstein HC, Holloway AC. Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction. PLoS ONE 2008; 3(10): e3371.
47. Yang L. Tobacco control necessary. China Daily 2011. Available at http://www.chinadaily.com.cn/opinion/2011-01/10/content_11815752.htm. Accessed on 1 March 2011.
48. Jin LN, Huang Y, Bi Y, et al. Association between alcohol consumption and metabolic syndrome in 19215 middle-aged and elderly Chinese. Diabetes Res Clin Pract 2011; 92(3): 386-92.
49. Gupta PC, Maulik PK, Pednekar MS, Saxena S. Concurrent alcohol and tobacco use among a middle-aged and elderly population in Mumbai. Natl Med J India 2005; 18(2): 88-91.
50. Schulze MB, Hoffmann K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005; 82(3): 675-84.
51. Xu Y, Zhao Z, Li X, Bi Y, Xu M, Ning G. Relationship between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population. Endocrine 2011; 39(2): 175-81.
52. Li XY, Xu M, Wang JG, et al. Serum C-reactive protein (CRP) and microalbuminuria in relation to fasting and 2-h postload plasma glucose in a Chinese population. Clin Endocrinol (Oxf) 2009; 70(5): 691-7.
53. Huang Y, Xu M, Hong J, Gu W, Bi Y, Li X. -607 C/A polymorphism in the promoter of IL-18 gene is associated with 2h post-loading plasma glucose level in Chinese. Endocrine 2010; 37(3): 507-12.
54. Lastra G, Manrique CM, Hayden MR. The role of beta-cell dysfunction in the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1(1): 41-6.
55. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr 2007; 83(5): S192-203.
56. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11(2): 85-97.
57. Sánchez F, García R, Alarcón F, Cruz M. Adipocinas, tejido adiposo y su relación con células del sistema inmune. Gac Méd Méx 2005; 141(16): 505-12.
58. Pyrzak B, Ruminska M, Popko K, Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur J Med Res 2010; 15(2): 147-51.
59. Hennige AM, Staiger H, Wicke C, et al. Fetuin A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008; 3(3): e1765.
60. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association Between Human Fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006; 113(14): 1760-7.
61. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and gatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008; 93(11): 4479-85.
62. Li M, Xu M, Bi Y, et al. Association between higher serum fetuin-a concentrations and abnormal albuminuria in middle-aged and elderly Chinese with normal glucose tolerance. Diabetes Care 2010; 33(11): 2462-4.
63. Xu Y, Xu M, Bi Y, et al. Serum fetuin-A is correlated with metabolic syndromein middle-aged and elderly Chinese. Atherosclerosis 2011; 216(1): 180-6.
64. Song A, Xu M, Bi Y, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS ONE 2011; 6(4): e19228.
65. Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20(8): 1676-85.
66. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 1989; 58(4): 631-40.
67. Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000; 2: 87-98.
68. Srinivas PR, Wagner AS, Reddy LV, et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993; 7(15): 1445-55.
69. Rauth G, Pöschke O, Fink E, et al. The nucleotide and partial amino acid sequences of rat fetuin: identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem 1992; 204(2): 523-9.
70. Burridge E. Bisphenol A: product profile. Eur Chem News 2003; 78(2048): 17.
71. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113(4): 391-5.
72. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008; 116(1): 39-44.
73. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24(2): 139-77.
74. Lang IA, Galloway TS, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300(11): 1303-10.
75. Ning G, Bi Y, Wang T, et al. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis. Ann Intern Med 2011; 155(6): 368-74.
76. Wang T, Li M, Chen B, et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012; 97(2): E223-7.
77. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB. The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 2009; 2: 63-8.
78. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 2008; 3(4): e2069.
79. Alonso-Magdalena P, Laribi O, Ropero AB, et al. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 2005; 113(8): 969-77.
80. Dekant W, Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008; 228(1): 114-34.
81. Vogel SA. The politics of plastics: the making and unmaking of bisphenol a "safety". Am J Public Health 2009; 3: S559-66.
82. Wetherill YB, Akingbemi BT, Kanno J, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007; 24(2): 178-98.
83. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008; 116(12): 1642-7.
84. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308(5720): 385-9.
85. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 1092-7.
86. Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40(9): 1098-102.
87. Saxena R, Hivert MF, Langenberg C, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010; 42(2): 142-8.
88. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42(7): 579-89.
89. Xiang J, Li XY, Xu M, et al. Zinc transporter-8 (SLC30A8) is associated with type 2 diabetes in Chinese. J Clin Endocrinol Metab 2008; 93(10): 4107-12.
90. Cui B, Zhu X, Xu M, et al. A genome-wide association study confirms previously reported loci for type 2 diabetes in Han Chinese. PLoS ONE 2011; 6(7): e22353.
91. Xu M, Bi Y, Xu Y, et al. Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS ONE 2010; 5(11): e14022.
92. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461(7265): 747-53.
93. McCarthy MI. Casting a wider net for diabetes susceptibility genes. Nat Genet 2008; 40(9): 1039-40.
94. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117(8): 2155-63.
95. Fischer J, Koch L, Emmerling C, et al. Inactivation of the Fto gene protects from obesity. Nature 2009; 458(7240): 894-8.
96. Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008; 51(7): 1100-10.
97. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med 2006; 355(3): 241-50.
98. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008; 359(21): 2208-19.
99. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008; 359(21): 2220-32.